Urinary Tract Infections Caused by Extended-spectrum Beta-lactamase-producing Enterobacteria

NCT06910878 | Recruiting

• 1 other identifier: 9307
• Study Type: observational
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

Urinary tract infections (UTIs) are one of the most common pathologies encountered in general practice. However, with increasing bacterial resistance to antibiotics, their treatment is becoming increasingly complex. Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) pose a particular challenge due to their increased resistance to many commonly used antibiotics. The aim of this thesis is to study the management of such infections by general practitioners in Bas-Rhin and to suggest possible avenues for improvement.

Conditions

Urinary Tract Infections

Keywords

Urinary Tract Infections; Beta-Lactamase; Enterobacteriaceae

Outcome Measures

Primary Outcomes (1)

• Prescription rates of appropriate antibiotics for the treatment of ESBL-E UTIs

  Prescription rates of appropriate antibiotics for the treatment of ESBL-E UTIs by general practitioners compared to current health authority recommendations

  Up to 1 year

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Adult (≥18 years old) with an Enterobacteriaceae urinary tract infection treated in a primary care setting for urinary tract infection between June 1, 2024 and December 31, 2024

You may qualify if:

• Adult (≥18 years old)
• Subject with an Enterobacteriaceae urinary tract infection treated in a primary care setting for urinary tract infection between June 1, 2024 and December 31, 2024
• Subject not objecting, after being informed, to the reuse of their data for the purposes of this research.
• The subject's primary care physician agreeing to participate in the study

You may not qualify if:

• Subject and/or their primary care physician having expressed their opposition to participating in the study
• Subject under legal protection
• Subject under guardianship or curatorship

Sponsors & Collaborators

• University Hospital, Strasbourg, France: lead

Study Sites (1)

Service de maladies infectieuses et tropicales - Hôpitaux Universitaires de Strasbourg

Strasbourg, France

RECRUITING

MeSH Terms

Conditions

Urinary Tract Infections

Condition Hierarchy (Ancestors)

Infections; Urologic Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Male Urogenital Diseases

Central Study Contacts

Yves HANSMANN, MD, PhD

CONTACT

33 3 69 55 09 78; yves.hansmann@chru-strasbourg.fr

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 28, 2025
• First Posted: April 4, 2025
• Study Start: October 24, 2024
• Primary Completion: December 24, 2025
• Study Completion: December 24, 2025
• Last Updated: April 4, 2025

Record last verified: 2025-03

Locations

FR (1)